Rhea launches with senior advisory panel, growth acquisitions and strategic partnerships to support the fertility journey for the modern family

The launch coincides with another round of financing led by Thiel Capital to expand its global footprint

Singapore–(ANTARA/Business Wire)– Rhea, a global reproductive health services company focused on improving fertility for the modern family, today announced its official launch. Rhea is the first comprehensive reproductive health ecosystem, connecting future families in Asia with complementary sites in North America and Europe to provide a high standard of comprehensive care in all geographic locations.

The Rhea service ecosystem is centered around a global network of own and partner clinics. This ecosystem is powered by Rhea Labs, an integrated technology platform that leverages data, accelerates time-to-market and high-quality product feedback loops to improve patient outcomes. The company’s fertility services are delivered through Rhea’s patient journey management tools and its Generation Prime clinic network, which has formally changed its name to GenPrime.

The company announced another round led by returning investor Thiela Capital, with participation from funds such as LifeX Ventures, Blue Lion Global and FJ Labs. The additional funds will be used to expand Rhea’s reach and service offerings into new markets.

In parallel with the new financing, Rhea announced the acquisition of Embryonics, a company that uses a suite of innovative artificial intelligence technologies to improve the process and outcomes of infertility treatment. The Embryonics team and its AI diagnostic tools have been integrated into Rhea Labs, using data-driven science to refine Rhea’s product roadmap. Rhea Labs is also building RheaX, a global gamete exchange platform, providing first-class solutions to streamline the gamete matching and transfer process. The exchange will be developed through Rhea’s joint venture with Baylor College of Medicine, a health sciences university located at the Texas Medical Center, the largest medical center in the world. Rhea is also working closely with Baylor to launch a joint award for reproductive health research this fall.

To support its development, Rhea formally established its senior advisory panel, which included:

• Dr. Milton Leong, pioneer of in vitro fertilization in Hong Kong and founding president of the Hong Kong Society of Reproductive Medicine. Dr. Leong was responsible for the first IVF baby in Hong Kong in 1985. He has been a specialist in reproductive medicine for over 30 years and is the co-founder of IVF Worldwide;

• Cynthia Hudson, vice president of clinical strategy at TMRW Life Sciences. Hudson co-founded Kindbody, a leading network of fertility clinics and family-building benefits providers in the United States, and has over 20 years of experience in reproductive technology;

• Dr. Javaid I. Sheikh, dean of Weill Cornell Medicine – Qatar. Dean Sheikh is a renowned medical director and former chairman of the board of directors of the Palo Alto Institute for Research and Education at Stanford University School of Medicine and the Veterans Administration Palo Alto Health Care System in California;

• Dr. Michael Coburn, professor and chair of Urology at Baylor College of Medicine. Professor Coburn served as Chief of Urology at Ben Taub Hospital from 1990 to 2012 and is a member of the Board of Governors of the American College of Surgeons. He is the recipient of the Robertson Presidential Educator Award for lifetime achievement in educational leadership at Baylor College of Medicine;

• Bea Camacho, director of Southeast Asia at IDEO. Camacho has extensive experience in designing human-centric digital services and products, developing new business ventures and building innovation capacity. Its clients include healthcare, education, hospitality, financial services and consumer goods industries, including Merck, Medtronic, Roche, IKEA, Nike and Marriott.

• Weylin Liew, Global Sustainability Portfolio Manager and Director of Active Engagement at Singapore’s sovereign wealth fund GIC. Weylin is also the co-founder of Fertility Support SG, a registered charity focusing on reproductive health resources and support in Singapore.

Margaret Wang, managing partner at Recharge Capital and former director of Bridgewater Associates Singapore, was appointed CEO of Rhea after joining the company in 2023. The Rhea incubator was led by Recharge Capital, the first thematic private investment firm driving innovation in women’s healthcare solutions. Recharge Capital remains a key investor in the company.

“The current fertility market is fragmented and diverse, creating unnecessary barriers for expectant parents as they face the challenges of realizing their dreams of building a family,” said Margaret Wang, CEO of Rhea. “Through our growing network of clinics, advanced Rhea Labs solutions and guidance from our world-class advisors, we provide a modern and integrated ecosystem of services, technologies and partnerships to advance reproductive health efforts around the world.”

The company, based in Singapore and New York, US, plans to continue its acquisition strategy in 2024 and expand its geographic reach for patients in new regions.

About Rhea

Rhea is a modern, global reproductive health services company, making fertility easier for today’s family. The company’s clinical services are provided through the Rhea GenPrime network of clinics and a growing number of partner clinics. The company’s clinic network is powered by Rhea Labs, an integrated technology platform that leverages a flywheel of accelerated time to market and short product feedback loops to improve patient outcomes. Incubated and developed by Recharge Capital, a leading thematically focused investment firm, Rhea is a Cayman entity based in Singapore and New York, USA, serving markets throughout Asia with additional operations in North America and Europe.

Communication

Media

Abdullah Alkudsi

Bias

source: Rhea